pMRX-IP TFEB-sfGFP Citations (1)
Originally described in: Identification of a factor controlling lysosomal homeostasis using a novel lysosomal trafficking probe.Ishii S, Matsuura A, Itakura E Sci Rep. 2019 Aug 12;9(1):11635. doi: 10.1038/s41598-019-48131-2. PubMed Journal
Articles Citing pMRX-IP TFEB-sfGFP
Articles |
---|
Pharmacological CDK4/6 inhibition promotes vulnerability to lysosomotropic agents in breast cancer. Nehme J, Maassen S, Bravaccini S, Zanoni M, Gianni C, De Giorgi U, Soto-Gamez A, Altulea A, Gheorghe T, Wang B, Demaria M. EMBO J. 2025 Apr;44(7):1921-1942. doi: 10.1038/s44318-025-00371-x. Epub 2025 Feb 10. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.